A Dark Vector Cognition product

Item 5. Other Information

2K characters. Original on sec.gov · Markdown

Item 5. Other Information

Rule 10b5-1 Trading Plans

Our policy governing transactions in our securities by our directors, officers, and employees permits our officers, directors and employees to enter into trading plans complying with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The following table describes the written plans for the sale of our securities adopted by our executive officers and directors during the second quarter of 2023, each of which is intended to satisfy the affirmative defense conditions of Rule 10b5-1 (each, a “Trading Plan”).

Name and TitleDate of Adoption of Trading PlanScheduled Expiration Date of Trading Plan (1)Maximum Shares Subject to Trading Plan
David Altshuler EVP, Global Research and Chief Scientific Officer5/10/20235/17/202432,896(2)
Carmen Bozic EVP, Global Medicines Development and Medical Affairs, Chief Medical Officer5/30/20231/31/202433,905
Amit Sachdev EVP, Chief Patient Officer5/9/20235/20/202440,128(2)
Ourania Tatsis EVP, Chief Regulatory and Quality Officer5/9/20235/1/202411,783(2)
Sangeeta Bhatia Director5/10/20235/10/20241,194
Terrence Kearney Director5/9/202312/29/202310,000
(1) A Trading Plan may expire on an earlier date if all contemplated transactions are completed before such Trading Plan’s expiration date, upon termination by broker or the holder of the Trading Plan, or as otherwise provided in the Trading Plan. (2) Does not include shares of common stock that may be withheld for taxes at future vesting dates.

Previous: Item 1A. Risk Factors · Next: Item 6. Exhibits